Učitavanje...

Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer

PURPOSE: The objective of this research was to compare the short- and long-term efficacy of the following four neoadjuvant chemotherapy (NAC) regimens: docetaxel/carboplatin/trastuzumab (TCH), docetaxel/epirubicin/cyclophosphamide (TEC), Xeloda/epirubicin/cyclophosphamide followed by Xeloda/docetaxe...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Drug Des Devel Ther
Glavni autori: Li, Si, Wei, Wei, Jiang, Yi, Li, Qiuyun, Huang, Qinghua, Yang, Huawei, Liu, Jianlun
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6157574/
https://ncbi.nlm.nih.gov/pubmed/30275685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S171534
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!